Skip to contents

A dataframe containing 10,000 iterations of a probabilistic analysis.

Usage

df_pa

Format

A dataframe with 10,000 rows, each row being the inputs and (intermediate) outputs of a single probabilistic iteration, and 35 variables:

p_pfspd

Probability to transit from the progression-free survival (PFS) to progressed disease (PD) health state

p_pfsd

Probability to transit from the PFS to Death (D) health state

p_pdd

Probability to transit from the PD to D health state

p_dd

Probability to transit from the D to D health state

rr

Relative effectiveness of the treatment (_int)

u_pfs

Utility value (per cycle) associated with PFS health state

u_pd

Utility value (per cycle) associated with PD health state

u_d

Utility value (per cycle) associated with D health state

u_ae

Utility decrement associated with the occurrence of an adverse event

c_pfs

Costs (per cycle) associated with PFS health state

c_pd

Costs (per cycle) associated with PD health state

c_d

Costs (per cycle) associated with D health state

c_thx

Costs (per cycle) associated with receiving treatment, in the PFS health state

c_ae

Costs associated with experiencing an adverse event

t_qaly_comp

Total undiscounted QALY obtained with the comparator, i.e. no treatment administered

t_qaly_int

Total undiscounted QALY obtained with the intervention, i.e. treatment administered

t_qaly_d_comp

Total discounted QALY obtained with the comparator, i.e. no treatment administered

t_qaly_d_int

Total discounted QALY obtained with the intervention, i.e. treatment administered

t_costs_comp

Total undiscounted costs obtained with the comparator, i.e. no treatment administered

t_costs_int

Total undiscounted costs obtained with the intervention, i.e. treatment administered

t_costs_d_comp

Total discounted costs obtained with the comparator, i.e. no treatment administered

t_costs_d_int

Total discounted costs obtained with the intervention, i.e. treatment administered

t_ly_comp

Total undiscounted LY obtained with the comparator, i.e. no treatment administered

t_ly_int

Total undiscounted LY obtained with the intervention, i.e. treatment administered

t_ly_d_comp

Total discounted LY obtained with the comparator, i.e. no treatment administered

t_ly_d_int

Total discounted LY obtained with the intervention, i.e. treatment administered

t_ly_pfs_d_comp

Total discounted life years accrued in PFS health state, comparator strategy

t_ly_pfs_d_int

Total discounted life years accrued in PFS health state, intervention strategy

t_ly_pd_d_comp

Total discounted life years accrued in PD health state, comparator strategy

t_ly_pd_d_int

Total discounted life years accrued in PD health state, intervention strategy

t_qaly_pfs_d_comp

Total discounted quality-adjusted life years accrued in PFS health state, comparator strategy

t_qaly_pfs_d_int

Total discounted quality-adjusted life years accrued in PFS health state, intervention strategy

t_qaly_pd_d_comp

Total discounted quality-adjusted life years accrued in PD health state, comparator strategy

t_qaly_pd_d_int

Total discounted quality-adjusted life years accrued in PD health state, intervention strategy

t_costs_pfs_d_comp

Total discounted costs accrued in PFS health state, comparator strategy

t_costs_pfs_d_int

Total discounted costs accrued in PFS health state, intervention strategy

t_costs_pd_d_comp

Total discounted costs accrued in PD health state, comparator strategy

t_costs_pd_d_int

Total discounted costs accrued in PD health state, intervention strategy

t_qaly_ae_int

Quality-adjusted life year decrement associated with the occurence of adverse events, intervention strategy

t_costs_ae_int

Costs associated with the occurence of adverse events, intervention strategy

inc_ly

Incremental QALYs obtained with the intervention versus the comparator

inc_qaly

Incremental QALYs obtained with the intervention versus the comparator

inc_costs

Incremental costs obtained with the intervention versus the comparator